ISRCTN12125882 - Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma - Study Protocol

BACKGROUND: Excessive wound healing, with scarring of the episcleral tissue or encapsulation of the filtering bleb is the main reason for failure in trabeculectomy. Ranibizumab, an inhibitor of the Vascular Endothelial Growth Factor (VEGF), is seen as a promising candidate to prevent or treat extens...

Descripción completa

Detalles Bibliográficos
Autores principales: Bochmann, Frank, Kaufmann, Claude, Becht, Christoph N, Guber, Ivo, Kaiser, Michael, Bachmann, Lucas M, Thiel, Michael A
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2011
Materias:
Study Protocol
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034719/
https://www.ncbi.nlm.nih.gov/pubmed/21241468
http://dx.doi.org/10.1186/1471-2415-11-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3034719/
https://www.ncbi.nlm.nih.gov/pubmed/21241468
http://dx.doi.org/10.1186/1471-2415-11-1

Ejemplares similares